{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:44:31Z","timestamp":1791859471489,"version":"4.3.4"},"reference-count":23,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T00:00:00Z","timestamp":1595721600000},"content-version":"unspecified","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N011775\/1"],"award-info":[{"award-number":["MR\/N011775\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,6,16]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>In immune-mediated inflammatory diseases, there is a lack of -estimates of glucocorticoid dose\u2013response diabetes risk that consider changes in prescribed dose over time and disease activity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>Population-based longitudinal analysis of electronic health records from the UK Clinical Practice Research Datalink, linked to hospital admissions and the mortality registry (1998\u20132017). We included 100 722 adult patients without diabetes history, diagnosed with giant cell arteritis or polymyalgia rheumatica (n=32 593), inflammatory bowel disease (n=29 272), rheumatoid arthritis (n=28 365), vasculitis (n=6082), or systemic lupus erythematosus (n=4410). We estimated risks and HRs of type 2 diabetes associated with time-variant daily and total cumulative prednisolone-equivalent glucocorticoid dose using Cox regression methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Average patient age was 58.6 years, 65 469 (65.0%) were women and 8858 (22.6%) had a body mass index (BMI) \u226530 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Overall, 8137 (8.1%) people developed type 2 diabetes after a median follow-up of 4.9 years. At 1 year, the cumulative risk of diabetes increased from 0.9% during periods of non-use to 5.0% when the daily prednisolone-equivalent dose was \u226525.0 mg. We found strong dose-dependent associations for all immune-mediated diseases, BMI levels and underlying disease duration, even after controlling for periods of active systemic inflammation. Adjusted HR for a &lt;5.0 mg daily dose versus non-use was 1.90, 95% CI 1.44 to 2.50; range 1.70 for rheumatoid arthritis to 2.93 for inflammatory bowel disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We report dose-dependent risks of type 2 diabetes associated with glucocorticoid use for six common immune-mediated inflammatory diseases. These results underline the need for regular diabetic risk assessment and testing during glucocorticoid therapy in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001220","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T01:58:00Z","timestamp":1595901480000},"page":"e001220","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis"],"prefix":"10.1136","volume":"8","author":[{"given":"Jianhua","family":"Wu","sequence":"first","affiliation":[{"name":"School of Dentistry, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L","family":"Mackie","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-1028","authenticated-orcid":false,"given":"Mar","family":"Pujades-Rodriguez","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Leeds, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"2025073112304172000_8.1.e001220.1","first-page":"62","article-title":"Steroid diabetes: from mechanism to treatment?","volume":"72","author":"van Raalte","year":"2014","journal-title":"Neth J Med"},{"key":"2025073112304172000_8.1.e001220.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050541"},{"key":"2025073112304172000_8.1.e001220.3","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40264-015-0339-z","article-title":"Drug-Induced hyperglycaemia and diabetes","volume":"38","author":"Fathallah","year":"2015","journal-title":"Drug Safety"},{"key":"2025073112304172000_8.1.e001220.4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420010131015"},{"key":"2025073112304172000_8.1.e001220.5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"The Lancet"},{"key":"2025073112304172000_8.1.e001220.6","doi-asserted-by":"crossref","first-page":"l5003","DOI":"10.1136\/bmj.l5003","article-title":"Trends in incidence of total or type 2 diabetes: systematic review","volume":"98","author":"Magliano","year":"2019","journal-title":"BMJ"},{"key":"2025073112304172000_8.1.e001220.7","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","author":"Zhou","year":"2016","journal-title":"The Lancet"},{"key":"2025073112304172000_8.1.e001220.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.10.029"},{"key":"2025073112304172000_8.1.e001220.9","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12090"},{"key":"2025073112304172000_8.1.e001220.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.33378"},{"key":"2025073112304172000_8.1.e001220.11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000365892","article-title":"Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis","volume":"65","author":"Liu","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"2025073112304172000_8.1.e001220.12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3803\/EnM.2017.32.2.180","article-title":"Glucocorticoid-Induced diabetes mellitus: an important but overlooked problem","volume":"32","author":"Suh","year":"2017","journal-title":"Endocrinol Metab"},{"key":"2025073112304172000_8.1.e001220.13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/17571472.2015.1082344","article-title":"Steroid-Induced hyperglycaemia in primary care","volume":"7","author":"Mills","year":"2015","journal-title":"London J Prim Care"},{"key":"2025073112304172000_8.1.e001220.14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2002.10649.x"},{"key":"2025073112304172000_8.1.e001220.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1499"},{"key":"2025073112304172000_8.1.e001220.16","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000521"},{"key":"2025073112304172000_8.1.e001220.17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.39537","article-title":"Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis","volume":"68","author":"Movahedi","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025073112304172000_8.1.e001220.18","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025073112304172000_8.1.e001220.19","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2019-00153","article-title":"Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England","author":"Mebrahtu","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2025073112304172000_8.1.e001220.20","doi-asserted-by":"crossref","unstructured":"Wu J , Keeley A , Mallen C , et al . Incidence of infections associated with oral glucocorticoid dose in people diagnosed with polymyalgia rheumatica and giant cell arteritis: a cohort study in England. CMAJ. In Press 2019.","DOI":"10.1503\/cmaj.190178"},{"key":"2025073112304172000_8.1.e001220.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.300.6732.1092","article-title":"The read clinical classification","volume":"300","author":"Chisholm","year":"1990","journal-title":"BMJ"},{"key":"2025073112304172000_8.1.e001220.22","unstructured":"Hain D . Index of multiple deprivation score, 2007, 2007. Available: https:\/\/data.gov.uk\/dataset\/5ceb7e93-bc1a-48cf-80fd-fbdd15909640\/index-of-multiple-deprivation-score-20072019 [Accessed 25 Nov 2019]."},{"key":"2025073112304172000_8.1.e001220.23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:30:53Z","timestamp":1753990253000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,27]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjdrc-2020-001220"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001220","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}